Skip to main content
Clinical Trials/CTRI/2019/05/019341
CTRI/2019/05/019341
Not yet recruiting
Phase 1

A prospective randomized controlled trial to compare the efficacy and safety of different doses of clonidine when used as an adjuvant to intrathecal bupivacaine

J J hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: S729- Unspecified fracture of femurHealth Condition 2: S929- Unspecified fracture of foot and toeHealth Condition 3: S829- Unspecified fracture of lower leg
Sponsor
J J hospital
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
J J hospital

Eligibility Criteria

Inclusion Criteria

  • ASA I or II normotensive patients undergoing elective orthopaedic surgery

Exclusion Criteria

  • ASA III \& above, patients with cardiovascular, renal, liver dysfunction, allergy to clonidine or bupivacaine, short height ( \<130cm), obese(BMI \> 30kg/m2\) or with contraindication to spinal

Outcomes

Primary Outcomes

Not specified

Similar Trials